The evolving approach to paediatric myocarditis: A review of the current literature

Cardiology in the Young

Volumn 21, Issue 3, 2011, Pages 241-251

  May, Lindsay J ^a   Patton, David J ^a,b   Fruitman, Deborah S ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Cardiomyopathy; myocardium; ventricular dysfunction

Indexed keywords

AZATHIOPRINE; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOGLOBULIN; PREDNISOLONE; PREDNISONE; TROPONIN; TROPONIN I; TROPONIN T;

CARDIAC IMAGING; CHILD HEALTH CARE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE MARKER; DRUG EFFICACY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; GOLD STANDARD; HEART MUSCLE BIOPSY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOTAL QUALITY MANAGEMENT;

BIOLOGICAL MARKERS; HUMANS; MYOCARDITIS; PEDIATRICS; PROGNOSIS; TREATMENT OUTCOME;

EID: 79956043712     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951110001964     Document Type: Review

References (112)

1. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-842. (Pubitemid 26074816)
2. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-1398.
3. Press S, Lipkind RS. Acute myocarditis in infants. Initial presentation. Clin Pediatr (Phila) 1990; 29: 73-76. (Pubitemid 20077850)
4. Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 2008; 3: 127-155. (Pubitemid 351488278)
5. Freedman SB, Haladyn JK, Floh A, et al. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics 2007; 120: 1278-1285. (Pubitemid 350223679)
6. Okada R, Kawai S, Kasyuya H. Nonspecific myocarditis: a statistical and clinicopathological study of autopsy cases. Jpn Circ J 1989; 53: 40-48. (Pubitemid 19111181)
7. Waller BF, Catellier MJ, Clark MA, et al. Cardiac pathology in 2007 consecutive forensic autopsies. Clin Cardiol 1992; 15: 760-765.
8. Daubeney PE, Nugent AW, Chondros P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 2006; 114: 2671-2678. (Pubitemid 44967351)
9. Eckart RE, Scoville SL, Campbell CL, et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 2004; 141: 829-834. (Pubitemid 39601175)
10. Whitton JL, Feuer R. Myocarditis, microbes and autoimmunity. Autoimmunity 2004; 37: 375-386. (Pubitemid 40100695)
11. Bowles NE, Towbin JA. Molecular aspects of myocarditis. Curr Opin Cardiol 1998; 13: 179-184. (Pubitemid 28254456)
12. Chany C, Lepine P, Lelong M, et al. Severe and fatal pneumonia in infants and young children associated with adenovirus infections. Am J Hyg 1958; 67: 367-378.
13. Hirschman SZ, Hammer GS. Coxsackie virus myopericarditis. A microbiological and clinical review. Am J Cardiol 1974; 34: 224-232.
14. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994; 90: 330-339. (Pubitemid 24203696)
15. Drew JH. Echo 11 virus outbreak in a nursery associated with myocarditis. Aust Paediatr J 1973; 9: 90-95.
16. Rosenberg HS, McNamara DG. Acute Myocarditis in Infancy and Childhood. Prog Cardiovasc Dis 1964; 7: 179-197.
17. Woodruff JF. Viral myocarditis. A review. Am J Pathol 1980; 101: 425-484.
18. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42: 466-472. (Pubitemid 36951713)
19. Kuhl U, Pauschinger M, Seeberg B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005; 112: 1965-1970. (Pubitemid 41377415)
20. Bratincsak A, El-Said HG, Bradley JS, et al. Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children. J Am Coll Cardiol 2010; 55: 928-929.
21. Leonard EG. Viral myocarditis. Pediatr Infect Dis J 2004; 23: 665-666. (Pubitemid 38924893)
22. Calabrese F, Rigo E, Milanesi O, et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 2002; 11: 212-221. (Pubitemid 35364936)
23. Durani Y, Egan M, Baffa J, et al. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med 2009; 27: 942-947.
24. Kern J, Modi R, Atalay MK, et al. Clinical myocarditis masquerading as acute coronary syndrome. J Pediatr 2009; 154: 612-615.
25. Ellis CR, Di Salvo T. Myocarditis: basic and clinical aspects. Cardiol Rev 2007; 15: 170-177. (Pubitemid 46956452)
26. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18: 619-624. (Pubitemid 17097832)
27. Grenier MA, Osganian SK, Cox GF, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000; 139: S86-S95. (Pubitemid 30091772)
28. Batra AS, Lewis AB. Acute myocarditis. Curr Opin Pediatr 2001; 13: 234-239. (Pubitemid 32505682)
29. Lippi G, Salvagno GL, Guidi GC. Cardiac troponins in pediatric myocarditis. Pediatrics 2008; 121: 864-865.
30. Franz WM, Remppis A, Kandolf R, et al. Serum troponin T: diagnostic marker for acute myocarditis. Clin Chem 1996; 42: 340-341.
31. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997; 95: 163-168. (Pubitemid 27029958)
32. Soongswang J, Durongpisitkul K, Nana A, et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol 2005; 26: 45-49. (Pubitemid 41569560)
33. Nasser N, Perles Z, Rein AJ, et al. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Pediatr Cardiol 2006; 27: 87-90.
34. Nir A, Bar-Oz B, Perles Z, et al. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 2004; 93: 603-607. (Pubitemid 38570224)
35. Checchia PA, Kulik TJ. Acute viral myocarditis: diagnosis. Pediatr Critical Care Med 2006; 7: S8-S11. (Pubitemid 44715285)
36. Mendes LA, Dec GW, Picard MH, et al. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 1994; 128: 301-307. (Pubitemid 24259154)
37. Jeserich M, Konstantinides S, Pavlik G, et al. Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol 2009; 98: 753-763.
38. Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-1822. (Pubitemid 40779862)
39. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008; 246: 401-409.
40. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998; 97: 1802-1809. (Pubitemid 28213624)
41. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004; 109: 1250-1258. (Pubitemid 38379570)
42. Skouri HN, Dec GW, Friedrich MG, et al. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006; 48: 2085-2093. (Pubitemid 44738442)
43. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487.
44. Friedrich MG. Myocardial edema - a new clinical entity? Nat Rev Cardiol 2010; 7: 292-296.
45. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007; 26: 452-459. (Pubitemid 350194566)
46. Cocker M, Friedrich MG. Cardiovascular magnetic resonance of myocarditis. Curr Cardiol Rep 2010; 12: 82-89.
47. Wagner A, Schulz-Menger J, Dietz R, et al. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. MAGMA 2003; 16: 17-20. (Pubitemid 38325344)
48. Cocker MS, Abdel-Aty H, Strohm O, et al. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart 2009; 95: 1925-1930.
49. Pophal SG, Sigfusson G, Booth KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999; 34: 2105-2110. (Pubitemid 30002672)
50. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol 1992; 19: 43-47.
51. Felker GM, Hu W, Hare JM, et al. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore) 1999; 78: 270-283. (Pubitemid 29343203)
52. Holzmann M, Nicko A, Kuhl U, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008; 118: 1722-1728.
53. Tominaga M, Matsumori A, Okada I, et al. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carvedilol in mice. Circulation 1991; 83: 2021-2028.
54. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001; 138: 505-511. (Pubitemid 32319723)
55. Gunthard J, Stocker F, Bolz D, et al. Dilated cardiomyopathy and thrombo-embolism. Eur J Pediatr 1997; 156: 3-6. (Pubitemid 26425769)
56. Bradley TD, Holloway RM, McLaughlin PR, et al. Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 1992; 145: 377-382.
57. Naughton MT, Rahman MA, Hara K, et al. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725-1731.
58. Bohn D, Benson L. Diagnosis and management of pediatric myocarditis. Paediatr Drugs 2002; 4: 171-181. (Pubitemid 34293252)
59. Sezai A, Hata M, Niino T, et al. Mechanical circulatory support for fulminant myocarditis. Surg Today 2008; 38: 773-777.
60. Potapov EV, Stiller B, Hetzer R. Ventricular assist devices in children: current achievements and future perspectives. Pediatr Transplant 2007; 11: 241-255. (Pubitemid 46570136)
61. Jones CB, Cassidy JV, Kirk R, et al. Successful bridge to recovery with 120 days of mechanical support in an infant with myocarditis. J Heart Lung Transplant 2009; 28: 202-205.
62. Parrillo JE, Cunnion RE, Epstein SE, et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989; 321: 1061-1068. (Pubitemid 19256658)
63. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators. N Engl J Med 1995; 333: 269-275.
64. Jones SR, Herskowitz A, Hutchins GM, et al. Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 1991; 68: 370-376.
65. Vignola PA, Aonuma K, Swaye PS, et al. Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression. J Am Coll Cardiol 1984; 4: 812-819. (Pubitemid 14012472)
66. McNamara DM, Rosenblum WD, Janosko KM, et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation 1997; 95: 2476-2478. (Pubitemid 27233111)
67. O'Connell JB, Mason JW. Immunosuppressive therapy in experimental and clinical myocarditis. Pathol Immunopathol Res 1988; 7: 292-304.
68. Maisch B, Herzum M, Hufnagel G, et al. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. Eur Heart J 1995; 16 Suppl O: 153-161. (Pubitemid 26082370)
69. Garg A, Shiau J, Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 1998; 129: 317-322. (Pubitemid 28394578)
70. Camargo PR, Snitcowsky R, da Luz PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16: 61-68.
71. Chan KY, Iwahara M, Benson LN, et al. Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial. J Am Coll Cardiol 1991; 17: 458-460.
72. Ciszewski A, Bilinska ZT, Lubiszewska B, et al. Dilated cardiomyopathy in children: clinical course and prognosis. Pediatr Cardiol 1994; 15: 121-126. (Pubitemid 24168154)
73. Balaji S, Wiles HB, Sens MA, et al. Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm. Br Heart J 1994; 72: 354-359. (Pubitemid 24322948)
74. Ino T, Okubo M, Akimoto K, et al. Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis. J Pediatr 1995; 126: 304-308.
75. Kleinert S, Weintraub RG, Wilkinson JL, et al. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression. J Heart Lung Transplant 1997; 16: 1248-1254. (Pubitemid 28023912)
76. Hia CP, Yip WC, Tai BC, et al. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004; 89: 580-584.
77. Robinson JL, Hartling L, Crumley E, et al. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord 2005; 5: 12.
78. Kishimoto C, Shioji K, Kinoshita M, et al. Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int J Cardiol 2003; 91: 173-178. (Pubitemid 38373441)
79. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103: 2254-2259. (Pubitemid 32433714)
80. Goland S, Czer LS, Siegel RJ, et al. Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature. Can J Cardiol 2008; 24: 571-574.
81. Takeda Y, Yasuda S, Miyazaki S, et al. High-dose immunoglobulin G therapy for fulminant myocarditis. Jpn Circ J 1998; 62: 871-872.
82. Shioji K, Matsuura Y, Iwase T, et al. Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report. Circ J 2002; 66: 977-980.
83. Tedeschi A, Airaghi L, Giannini S, et al. High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature. J Intern Med 2002; 251: 169-173. (Pubitemid 34146700)
84. Stouffer GA, Sheahan RG, Lenihan DJ, et al. The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin. Am J Med Sci 2003; 326: 369-374. (Pubitemid 37523570)
85. Karaaslan S, Oran B, Caliskan U, et al. Hemolysis after administration of high-dose immunoglobulin in a patient with myocarditis. Turk J Haematol 2003; 20: 237-240. (Pubitemid 37526745)
86. Abe S, Okura Y, Hoyano M, et al. Plasma concentrations of cytokines and neurohumoral factors in a case of fulminant myocarditis successfully treated with intravenous immunoglobulin and percutaneous cardiopulmonary support. Circ J 2004; 68: 1223-1226. (Pubitemid 40018873)
87. Drucker NA, Colan SD, Lewis AB, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252-257. (Pubitemid 24026497)
88. Nigro G, Bastianon V, Colloridi V, et al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis 2000; 31: 65-69. (Pubitemid 32268940)
89. Tsai YG, Ou TY, Wang CC, et al. Intravenous gammaglobulin therapy in myocarditis complicated with complete heart block: report of one case. Acta Paediatr Taiwan 2001; 42: 311-313.
90. Khan MA, Das B, Lohe A, et al. Neonatal myocarditis presenting as an apparent life threatening event. Clin Pediatr (Phila) 2003; 42: 649-652. (Pubitemid 37174434)
91. Kim HS, Sohn S, Park JY, et al. Fulminant myocarditis successfully treated with high-dose immunoglobulin. Int J Cardiol 2004; 96: 485-486. (Pubitemid 39099516)
92. Wang CY, Li Lu F, Wu MH, et al. Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 2004; 23: 275-276.
93. English RF, Janosky JE, Ettedgui JA, et al. Outcomes for children with acute myocarditis. Cardiol Young 2004; 14: 488-493.
94. Parrillo JE. Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy? Circulation 2001; 104: 4-6. (Pubitemid 32623279)
95. Lee KJ, McCrindle BW, Bohn DJ, et al. Clinical outcomes of acute myocarditis in childhood. Heart 1999; 82: 226-233. (Pubitemid 29362876)
96. Gagliardi MG, Bevilacqua M, Bassano C, et al. Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart 2004; 90: 1167-1171. (Pubitemid 39279904)
97. Duncan BW, Bohn DJ, Atz AM, et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001; 122: 440-448. (Pubitemid 32843941)
98. Kuhn B, Shapiro ED, Walls TA, et al. Predictors of outcome of myocarditis. Pediatr Cardiol 2004; 25: 379-384. (Pubitemid 38989524)
99. Lin CH, Chang JS, Li PC. The rescue of acute fulminant myocarditis by extracorporeal membrane oxygenation in pediatric patients. Acta Paediatr Taiwan 2005; 46: 201-205.
100. Wu ET, Huang SC, Chen YS, et al. Children with fulminant myocarditis rescued with extracorporeal membrane oxygenation. Heart 2006; 92: 1325-1326.
101. ECMO Registry of the Extracorporeal Life Support Organization (ELSO), Ann Arbor, Michigan, January 2008. https://www.elso. med.umich.edu
102. Rajagopal SK, Almond CS, Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the extracorporeal life support organization registry. Crit Care Med 2010; 38: 382-387.
103. Kolovos NS, Bratton SL, Moler FW, et al. Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery. Ann Thorac Surg 2003; 76: 1435-1441. (Pubitemid 37378289)
104. Chaturvedi RR, Macrae D, Brown KL, et al. Cardiac ECMO for biventricular hearts after paediatric open heart surgery. Heart 2004; 90: 545-551. (Pubitemid 38530173)
105. Morris MC, Ittenbach RF, Godinez RI, et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med 2004; 32: 1061-1069. (Pubitemid 38471531)
106. Hetzer R, Stiller B. Technology insight: use of ventricular assist devices in children. Nat Clin Pract Cardiovasc Med 2006; 3: 377-386. (Pubitemid 43978398)
107. Amabile N, Fraisse A, Bouvenot J, et al. Outcome of acute fulminant myocarditis in children. Heart 2006; 92: 1269-1273. (Pubitemid 44298878)
108. McCarthy RE 3rd, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000; 342: 690-695. (Pubitemid 30131421)
109. Chau EM, Chow WH, Chiu CS, et al. Treatment and outcome of biopsy-proven fulminant myocarditis in adults. Int J Cardiol 2006; 110: 405-406. (Pubitemid 43831216)
110. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997; 336: 1860-1866. (Pubitemid 27263973)
111. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104: 1076-1082. (Pubitemid 32803888)
112. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867-1876. (Pubitemid 44596196)